Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →

October 22, 2018 | News Release Review

Summary of diagnostic prostate cancer test study suffers from overreach

The test has only been performed in the laboratory, and is likely still years away from being available to actual patients.

2 Star

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

October 21, 2018 | Story Review

HealthDay speculates that experimental cystic fibrosis drug combo could be ‘breakthrough’ and ‘game-changing’

Thankfully, the story did mention the extremely steep cost of these drugs.

3 Star

3-Drug Therapy Might Be Cystic Fibrosis 'Breakthrough'

October 18, 2018 | Story Review

HealthDay touts nerve device as ‘more effective,’ but data is from unpublished study with no control group

But the story did a good job of reporting on the cost and availability of this procedure.

3 Star

New Nerve Stimulation Technique Might Relieve Back Pain

October 17, 2018 | News Release Review

News release touts universal blood test for cancer, but what about overdiagnosis?

It’s important to keep in mind that all cancer screening tests carry risks.

2 Star

'Universal' blood test for earlier diagnosis of cancer moves closer to market

October 16, 2018 | Story Review

Inquirer’s look at using Facebook to screen for depression emphasizes research ‘is still in very early stages’

It would have been helpful if the story had explored who would pay for this kind of screening, and what we know about depression screening in general: Is it effective?

4 Star

Depression often goes undiagnosed. Researchers are turning to Facebook to change that.

October 15, 2018 | News Release Review

Serious potential harms and financial conflicts missing in recap of study on vaginal laser surgery for menopausal symptoms

The release fails to mention that the FDA has issued a warning against the use of vaginal laser surgery for menopausal symptoms.

2 Star

Getting relief from sexual dysfunction and incontinence caused by menopause

October 12, 2018 | Story Review

Reuters once again rehashes drug company news release

There was also no information about how or where these research findings were presented, nor was there any input from independent experts.

2 Star

J&J's Stelara succeeds in chronic bowel disease study

October 11, 2018 | Story Review

Doctor’s $620,000 conflict of interest not disclosed in Inquirer story on new migraine drugs

But it was good to see how the story included the prices of the drugs and mentioned the lack of long-term safety data.

3 Star

Migraine patients can now try three new drugs for prevention


Tips & Resources for Analyzing Health Care Claims

View More


Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More


Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More